SAN FRANCISCO, Feb. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February 12, 2013, to discuss the Company's financial results for the third quarter of fiscal 2013 and to provide an update to the business.

The dial-in number for the live audio call beginning on Tuesday, February 12, 2013, at 5 p.m. EST (2 p.m. PST) is 877-369-6591 in the U.S. and 253-237-1176 for international participants. The conference identification number is 97663524. A live webcast of the conference call will also be available at:

http://investor.shareholder.com/media/eventdetail.cfm?eventid=125215&CompanyID=AMDA-1MQZB1&e=1&mediaKey=B72F44BB3E6E439488C570745B377AD3.

A webcast replay of the call will be available for one year and may be accessed at the same link:

http://investor.shareholder.com/media/eventdetail.cfm?eventid=125215&CompanyID=AMDA-1MQZB1&e=1&mediaKey=B72F44BB3E6E439488C570745B377AD3.

About CollabRx

CollabRx, Inc. (Nasdaq:CLRX) is a data analytics company and a leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com.

The CollabRx, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16990

CollabRx Contacts:
Thomas R. Mika, Chairman and CEO
CollabRx, Inc.
415-248-5350

Robert Ferri Partners, LLC
Robert Ferri
(415) 575-1589 (direct)